Compare VEEV & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VEEV | IQV |
|---|---|---|
| Founded | 2007 | 1982 |
| Country | United States | United States |
| Employees | N/A | 93000 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.3B | 35.1B |
| IPO Year | 2013 | 2013 |
| Metric | VEEV | IQV |
|---|---|---|
| Price | $192.11 | $201.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 25 | 16 |
| Target Price | ★ $280.42 | $227.13 |
| AVG Volume (30 Days) | ★ 1.9M | 1.4M |
| Earning Date | 05-27-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.93 | 4.67 |
| EPS | 1.57 | ★ 1.61 |
| Revenue | $1,104,081,000.00 | ★ $9,739,000,000.00 |
| Revenue This Year | $14.42 | $6.77 |
| Revenue Next Year | $12.17 | $5.89 |
| P/E Ratio | ★ $125.77 | $127.25 |
| Revenue Growth | 28.05 | ★ 41.60 |
| 52 Week Low | $148.05 | $154.50 |
| 52 Week High | $310.50 | $247.05 |
| Indicator | VEEV | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 62.39 | 52.31 |
| Support Level | $151.71 | $159.91 |
| Resistance Level | $202.59 | $226.63 |
| Average True Range (ATR) | 6.61 | 5.47 |
| MACD | 0.49 | -1.04 |
| Stochastic Oscillator | 68.39 | 20.82 |
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.